BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11036942)

  • 1. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
    Carter-Su C; Rui L; Stofega MR
    Recent Prog Horm Res; 2000; 55():293-311. PubMed ID: 11036942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.
    Carter-Su C; Rui L; Herrington J
    Pediatr Nephrol; 2000 Jul; 14(7):550-7. PubMed ID: 10912517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
    Rui L; Gunter DR; Herrington J; Carter-Su C
    Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
    Stofega MR; Argetsinger LS; Wang H; Ullrich A; Carter-Su C
    J Biol Chem; 2000 Sep; 275(36):28222-9. PubMed ID: 10842184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
    Rui L; Mathews LS; Hotta K; Gustafson TA; Carter-Su C
    Mol Cell Biol; 1997 Nov; 17(11):6633-44. PubMed ID: 9343427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
    Rui L; Carter-Su C
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signalling pathway of GH.
    Carter-Su C; King AP; Argetsinger LS; Smit LS; Vanderkuur J; Campbell GS
    Endocr J; 1996 Oct; 43 Suppl():S65-70. PubMed ID: 9076344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
    Stofega MR; Herrington J; Billestrup N; Carter-Su C
    Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone signaling pathways.
    Carter-Su C; Schwartz J; Argetsinger LS
    Growth Horm IGF Res; 2016 Jun; 28():11-5. PubMed ID: 26421979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
    VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
    J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
    VanderKuur JA; Wang X; Zhang L; Campbell GS; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1994 Aug; 269(34):21709-17. PubMed ID: 8063815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.
    O'Brien KB; Argetsinger LS; Diakonova M; Carter-Su C
    J Biol Chem; 2003 Apr; 278(14):11970-8. PubMed ID: 12551917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SH2-B family members differentially regulate JAK family tyrosine kinases.
    O'Brien KB; O'Shea JJ; Carter-Su C
    J Biol Chem; 2002 Mar; 277(10):8673-81. PubMed ID: 11751854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.